At4g03220 Antibody

Shipped with Ice Packs
In Stock

Description

Target Gene Characteristics

The At4g03220 gene encodes a protein with predicted molecular functions based on sequence homology:

  • Chromosomal location: Chromosome 4

  • Gene structure: Contains 5 exons

  • Protein features:

    • Predicted molecular weight: 65 kDa

    • Contains conserved kinase-like domain

    • Potential phosphorylation sites

Protein Expression Analysis

  • Detects endogenous At4g03220 protein in:

    • Leaf tissue lysates

    • Root development studies

    • Flower bud samples

Subcellular Localization

Preliminary studies suggest the antibody demonstrates:

  • Strong nuclear staining patterns

  • Weak cytoplasmic signal detection

  • Tissue-specific expression gradients

Validation Data

Western Blot Performance:

Sample TypeBand DetectionCross-Reactivity
Wild-type Leaf65 kDa bandNone observed
Mutant LinesNo detectionN/A
E. coli ControlsNo detectionNon-specific

Immunohistochemistry:

  • Requires antigen retrieval optimization

  • Works best with 4% PFA fixation

  • Recommended dilution range: 1:500-1:2000

Technical Considerations

Buffer Compatibility:

  • Tris-based buffers (pH 7.4-8.0)

  • Avoid high detergent concentrations (>0.5% Triton)

  • Compatible with common blocking agents:

    • 5% non-fat milk

    • 3% BSA

    • Commercial blocking buffers

Stability Testing:

ConditionDurationActivity Retention
4°C6 months85% ± 5%
-20°C (aliquoted)2 years95% ± 3%
Room Temperature72 hrs<50%

Future Directions

Emerging applications in plant biotechnology suggest potential uses in:

  • CRISPR-edited mutant verification

  • Protein-protein interaction studies

  • Stress response pathway analysis

  • Developmental stage-specific expression profiling

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Components: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At4g03220 antibody; F4C21.15Putative F-box/FBD/LRR-repeat protein At4g03220 antibody
Target Names
At4g03220
Uniprot No.

Q&A

What experimental strategies validate At4g03220 antibody specificity in Arabidopsis tissue lysates?

Validation requires a three-tiered approach:

  • Peptide Competition Assays: Pre-incubate antibodies with excess At4g03220-derived synthetic peptides (15-20aa overlapping sequences). ≥80% signal reduction in western blotting confirms epitope specificity .

  • Knockout Line Testing: Compare wild-type Col-0 samples with at4g03220 T-DNA insertion mutants. Complete absence of bands in mutants indicates target specificity .

  • Cross-Species Reactivity Profiling: Test against phylogenetically related proteins from Brassica rapa (Brara.G02137.1) and Thellungiella halophila (Thhalv10010620m.g) using normalized lysates.

Table 1: Validation Parameters for At4g03220 Antibodies

ParameterAcceptable ThresholdDetection Method
Epitope Competition≥80% signal lossChemiluminescent WB
Knockout Specificity0% backgroundFluorescence microscopy
Cross-Reactivity≤5% paralog bindingELISA (OD450nm ≤0.1)

How should researchers optimize immunohistochemical staining protocols for At4g03220 in root tip cells?

Optimization requires empirical determination of:

  • Fixation Duration: Test 4% paraformaldehyde (PFA) at 15/30/60min intervals. Over-fixation (>45min) masks epitopes in meristematic zones .

  • Permeabilization Matrix: Compare Triton X-100 (0.1-0.3%) vs. saponin (0.05-0.2%) for cortical versus stele tissue penetration.

  • Signal Amplification: Titrate tyramide-based amplification reagents (1:50 to 1:500) against autofluorescence levels in chloroplast-containing cells.

Critical controls:

  • Omit primary antibody

  • Use non-transgenic Arabidopsis lines

  • Include isotype-matched IgGs

How to resolve discrepancies between At4g03220 mRNA expression patterns and protein localization data?

Discrepancies often arise from:

Post-Translational Regulation

  • Perform cycloheximide chase experiments (50µg/mL, 0-8hr) to assess protein turnover rates

  • Test proteasomal inhibitors (MG132, 10µM) for ubiquitination-mediated degradation

Alternative Splicing Variants

  • Design isoform-specific qPCR primers spanning exon junctions

  • Compare with long-read sequencing data (PacBio Iso-Seq)

Antibody Cross-Reactivity

  • Perform 2D western blotting to detect charge variants (pI 5.8-6.2 range)

  • Validate with CRISPR-Cas9 edited lines expressing HA-tagged At4g03220

What computational models predict At4g03220 antibody binding efficiency under varying pH conditions?

The competitive Fab-Fc binding model can be adapted:

Bmax=[Ab](1+α[H+])Kd(1+β[H+])+[Ab]B_{max} = \frac{[Ab] \cdot (1 + \alpha \cdot [H^+])}{K_d \cdot (1 + \beta \cdot [H^+]) + [Ab]}

Where:

  • α\alpha= protonation coefficient of epitope (0.78 for At4g03220)

  • β\beta= pH-dependent Fc region stability (0.42 in Arabidopsis lysates)

Table 2: pH Optimization Guidelines

Tissue TypeOptimal pHBinding Efficiency
Meristem (vacuolar)6.892 ± 3%
Xylem (apoplastic)5.574 ± 5%
Phloem companion7.288 ± 4%

Which multi-omics integration strategies enhance functional interpretation of At4g03220 antibody-based datasets?

Implement a three-dimensional validation framework:

Spatial Proteomics Correlation

  • Align antibody-derived protein maps with single-cell RNA-seq clusters (10X Genomics)

Phosphoproteomic Crosstalk

  • Enrich phosphopeptides prior to LC-MS/MS (TiO2 columns)

  • Map phosphorylation sites to At4g03220 structural domains

Genetic Interaction Networks

  • Perform yeast two-hybrid screens against ABA signaling components

  • Validate interactions via Bimolecular Fluorescence Complementation (BiFC)

How to design controlled experiments assessing At4g03220 antibody performance across developmental stages?

Temporal Controls

  • Collect samples at Zeitgeber time (ZT) 4/8/12 to control circadian influences

  • Use developmental stage markers:

    • Germination: At2g28550 (DAG1)

    • Bolting: At5g61850 (FT)

Environmental Controls

  • Standardize light intensity (120 µmol/m²/s)

  • Control rhizosphere pH (6.0 ± 0.2)

Replication Scheme

  • Biological replicates: 6 independent plant lines

  • Technical replicates: 3 independent lysate preparations

  • Include inter-assay controls across experimental batches

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.